Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Background: Triple-negative breast cancer (TNBC) exhibits substantial variation in treatment response. In the phase 2 NeoSAC trial, higher baseline oxeiptosis-associated transcriptional activity was associated with pathological complete response (pCR). However, the malignant-cell and immune features underlying this transcriptional state remain poorly defined, as do the molecular factors that influence cellular susceptibility to oxidative stress.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
